The Result Of CCG 1961 Protocol Treatment With High Risk Acute Lymphoblastic Leukemia In Children

Downloads

Download data is not yet available.
PDF     76    15

Abstract

Background: Acute lymphoblastic leukemia (ALL) remains the most common malignancy in children. It accounts approximately 75% of all cases of childhood leukemia. High risk ALL in children can be cured treatment of high risk ALL in children at National Children’s Hospital (NCH).
Methods: Prospective study 102 patients from 6/2008 to 12/2012. The patients of high risk ALL was with the SPSS program.
Results: 88.24% achieved initial complete remission. According to Kaplan Meyer 5 years: 5- year overall survival (OS) is 48.6% ± 5.0; 5- year event free survival (EFS): 46% ± 5.0. Treatment of boys was better than of girls: OS and EFS were 54.8% and 52.9% compare with 30.5% and 29.6% respectively (p< 0,05). Rapid early response (RER) group had OS and EFS higher than slow early response (SER): 49.6% and 47.8% vs. 31.5% and 30.4%.
Conclusion: Overall survival and event free survival was 48.6% and 46%. Relapse rate was 16.7%. Mortality rate was 37.25%.

References

Nita LS, Steinherz P, Harland NS et al (2008). Early postinduction intensification therapy with high risk acute lymphoblastic leukemia: a report 111(5); 2548-55.

Allen Y, Sally B, Soh SY (2012). Ma- Spore ALL 2003 protocol progress report. Malignancies in Children. 6th St. Jude Viva Forum in Pediatric Oncology 2012. p. 138-56.

Arika Morimoto, Kikuko Kuriyama, Shigeyoshi Hibi (2005). Prognostic value of early response to treatment combined with conventional risk factor in pediatric acute lymphoblastic leukemia. Hematology, 81: 228- 234.

Châu Văn Hà, Nguyễn Đức Lương, Đinh Quang Tuấn (2012). Treatment Outcome of Childhood ALL and Effectiveness of Social Support at Huế Central Hospital, Vietnam from 2007- 2011. Malignancies in Children. 6th St. Jude Viva Forum. (Abst). 182.

Lauten M, Moricke A, Beier R et al (2012). Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica. 97: 1048- 1056.

Baruchel A (2010). Pediatric Regimens for Aldolescent and Young Adult. SIOP Education book. 60- 66.

Published 16-01-2025
Fulltext
PDF     76    15
Language
Issue No. 51 (2018)
Section Original article
DOI
Keywords Acute lymphoblastic leukemia, ALL, Overall survival OS, EFS

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital

Huong, N. T. M., Vien, B. V., Ha, T. T., Lan, B. N., Lan, P. T., & Huong, N. T. (2025). The Result Of CCG 1961 Protocol Treatment With High Risk Acute Lymphoblastic Leukemia In Children. Journal of Clinical Medicine Hue Central Hospital, (51), 3–7. Retrieved from https://jcmhch.com.vn/index.php/home/article/view/1029